Highlights

[PHARMA] QoQ Quarter Result on 2010-09-30 [#3]


View:


Show?  QoQ % Horiz. %

Quarter Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 396,435 385,328 376,116 334,337 350,335 317,560 323,906 14.46%
  QoQ % 2.88% 2.45% 12.50% -4.57% 10.32% -1.96% -
  Horiz. % 122.39% 118.96% 116.12% 103.22% 108.16% 98.04% 100.00%
PBT 19,380 21,792 -2,701 15,405 20,327 12,431 27,490 -20.84%
  QoQ % -11.07% 906.81% -117.53% -24.21% 63.52% -54.78% -
  Horiz. % 70.50% 79.27% -9.83% 56.04% 73.94% 45.22% 100.00%
Tax -5,335 -6,193 749 -6,970 -5,809 -3,122 -5,372 -0.46%
  QoQ % 13.85% -926.84% 110.75% -19.99% -86.07% 41.88% -
  Horiz. % 99.31% 115.28% -13.94% 129.75% 108.13% 58.12% 100.00%
NP 14,045 15,599 -1,952 8,435 14,518 9,309 22,118 -26.18%
  QoQ % -9.96% 899.13% -123.14% -41.90% 55.96% -57.91% -
  Horiz. % 63.50% 70.53% -8.83% 38.14% 65.64% 42.09% 100.00%
NP to SH 13,920 15,484 -2,256 8,586 14,747 9,307 21,914 -26.17%
  QoQ % -10.10% 786.35% -126.28% -41.78% 58.45% -57.53% -
  Horiz. % 63.52% 70.66% -10.29% 39.18% 67.29% 42.47% 100.00%
Tax Rate 27.53 % 28.42 % - % 45.25 % 28.58 % 25.11 % 19.54 % 25.76%
  QoQ % -3.13% 0.00% 0.00% 58.33% 13.82% 28.51% -
  Horiz. % 140.89% 145.45% 0.00% 231.58% 146.26% 128.51% 100.00%
Total Cost 382,390 369,729 378,068 325,902 335,817 308,251 301,788 17.15%
  QoQ % 3.42% -2.21% 16.01% -2.95% 8.94% 2.14% -
  Horiz. % 126.71% 122.51% 125.28% 107.99% 111.28% 102.14% 100.00%
Net Worth 451,517 437,661 421,262 424,488 417,065 439,675 431,217 3.12%
  QoQ % 3.17% 3.89% -0.76% 1.78% -5.14% 1.96% -
  Horiz. % 104.71% 101.49% 97.69% 98.44% 96.72% 101.96% 100.00%
Dividend
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Div - - - - 50,261 - 39,590 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 126.95% 0.00% 100.00%
Div Payout % - % - % - % - % 340.83 % - % 180.66 % -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 188.66% 0.00% 100.00%
Equity
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Net Worth 451,517 437,661 421,262 424,488 417,065 439,675 431,217 3.12%
  QoQ % 3.17% 3.89% -0.76% 1.78% -5.14% 1.96% -
  Horiz. % 104.71% 101.49% 97.69% 98.44% 96.72% 101.96% 100.00%
NOSH 106,994 107,007 106,919 106,924 106,939 106,977 107,001 -0.00%
  QoQ % -0.01% 0.08% -0.00% -0.01% -0.03% -0.02% -
  Horiz. % 99.99% 100.01% 99.92% 99.93% 99.94% 99.98% 100.00%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin 3.54 % 4.05 % -0.52 % 2.52 % 4.14 % 2.93 % 6.83 % -35.55%
  QoQ % -12.59% 878.85% -120.63% -39.13% 41.30% -57.10% -
  Horiz. % 51.83% 59.30% -7.61% 36.90% 60.61% 42.90% 100.00%
ROE 3.08 % 3.54 % -0.54 % 2.02 % 3.54 % 2.12 % 5.08 % -28.43%
  QoQ % -12.99% 755.56% -126.73% -42.94% 66.98% -58.27% -
  Horiz. % 60.63% 69.69% -10.63% 39.76% 69.69% 41.73% 100.00%
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
RPS 370.52 360.09 351.78 312.69 327.60 296.85 302.71 14.47%
  QoQ % 2.90% 2.36% 12.50% -4.55% 10.36% -1.94% -
  Horiz. % 122.40% 118.96% 116.21% 103.30% 108.22% 98.06% 100.00%
EPS 13.01 14.47 -2.11 8.03 13.79 8.70 20.48 -26.16%
  QoQ % -10.09% 785.78% -126.28% -41.77% 58.51% -57.52% -
  Horiz. % 63.53% 70.65% -10.30% 39.21% 67.33% 42.48% 100.00%
DPS 0.00 0.00 0.00 0.00 47.00 0.00 37.00 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 127.03% 0.00% 100.00%
NAPS 4.2200 4.0900 3.9400 3.9700 3.9000 4.1100 4.0300 3.13%
  QoQ % 3.18% 3.81% -0.76% 1.79% -5.11% 1.99% -
  Horiz. % 104.71% 101.49% 97.77% 98.51% 96.77% 101.99% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
RPS 151.76 147.51 143.98 127.99 134.11 121.56 123.99 14.47%
  QoQ % 2.88% 2.45% 12.49% -4.56% 10.32% -1.96% -
  Horiz. % 122.40% 118.97% 116.12% 103.23% 108.16% 98.04% 100.00%
EPS 5.33 5.93 -0.86 3.29 5.65 3.56 8.39 -26.16%
  QoQ % -10.12% 789.53% -126.14% -41.77% 58.71% -57.57% -
  Horiz. % 63.53% 70.68% -10.25% 39.21% 67.34% 42.43% 100.00%
DPS 0.00 0.00 0.00 0.00 19.24 0.00 15.16 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 126.91% 0.00% 100.00%
NAPS 1.7284 1.6754 1.6126 1.6250 1.5965 1.6831 1.6507 3.12%
  QoQ % 3.16% 3.89% -0.76% 1.79% -5.15% 1.96% -
  Horiz. % 104.71% 101.50% 97.69% 98.44% 96.72% 101.96% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Date 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 31/03/10 31/12/09 -
Price 5.9000 5.7300 5.3100 4.9800 4.9800 4.2700 4.0000 -
P/RPS 1.59 1.59 1.51 1.59 1.52 1.44 1.32 13.25%
  QoQ % 0.00% 5.30% -5.03% 4.61% 5.56% 9.09% -
  Horiz. % 120.45% 120.45% 114.39% 120.45% 115.15% 109.09% 100.00%
P/EPS 45.35 39.60 -251.66 62.02 36.11 49.08 19.53 75.63%
  QoQ % 14.52% 115.74% -505.77% 71.75% -26.43% 151.31% -
  Horiz. % 232.21% 202.76% -1,288.58% 317.56% 184.90% 251.31% 100.00%
EY 2.21 2.53 -0.40 1.61 2.77 2.04 5.12 -42.97%
  QoQ % -12.65% 732.50% -124.84% -41.88% 35.78% -60.16% -
  Horiz. % 43.16% 49.41% -7.81% 31.45% 54.10% 39.84% 100.00%
DY 0.00 0.00 0.00 0.00 9.44 0.00 9.25 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 102.05% 0.00% 100.00%
P/NAPS 1.40 1.40 1.35 1.25 1.28 1.04 0.99 26.07%
  QoQ % 0.00% 3.70% 8.00% -2.34% 23.08% 5.05% -
  Horiz. % 141.41% 141.41% 136.36% 126.26% 129.29% 105.05% 100.00%
Price Multiplier on Announcement Date
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Date 10/08/11 13/05/11 25/02/11 04/11/10 11/08/10 26/05/10 19/02/10 -
Price 5.9000 5.0500 5.3500 4.9200 4.9500 4.7100 4.0500 -
P/RPS 1.59 1.40 1.52 1.57 1.51 1.59 1.34 12.12%
  QoQ % 13.57% -7.89% -3.18% 3.97% -5.03% 18.66% -
  Horiz. % 118.66% 104.48% 113.43% 117.16% 112.69% 118.66% 100.00%
P/EPS 45.35 34.90 -253.55 61.27 35.90 54.14 19.78 74.14%
  QoQ % 29.94% 113.76% -513.82% 70.67% -33.69% 173.71% -
  Horiz. % 229.27% 176.44% -1,281.85% 309.76% 181.50% 273.71% 100.00%
EY 2.21 2.87 -0.39 1.63 2.79 1.85 5.06 -42.52%
  QoQ % -23.00% 835.90% -123.93% -41.58% 50.81% -63.44% -
  Horiz. % 43.68% 56.72% -7.71% 32.21% 55.14% 36.56% 100.00%
DY 0.00 0.00 0.00 0.00 9.49 0.00 9.14 -
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 103.83% 0.00% 100.00%
P/NAPS 1.40 1.23 1.36 1.24 1.27 1.15 1.00 25.22%
  QoQ % 13.82% -9.56% 9.68% -2.36% 10.43% 15.00% -
  Horiz. % 140.00% 123.00% 136.00% 124.00% 127.00% 115.00% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

236  475  591  1149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 VC 0.05-0.005 
 MAHSING 0.975-0.025 
 DATAPRP 0.20-0.02 
 KSTAR 0.445+0.075 
 LUSTER 0.165-0.005 
 SUPERMX-C1I 0.15-0.005 
 DGSB 0.22+0.005 
 SUPERMX 9.59-0.19 
 VIVOCOM 0.0450.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS